Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Australas J Dermatol ; 64(2): 194-203, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36892928

RESUMO

The CD30-postive lymphoproliferative disorders, including lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma, account for up to 30% of all cutaneous T-cell lymphomas (CTCLs) and are the second most common form of CTCLs after mycosis fungoides. Both conditions differ in their clinical presentations; however, they share the expression of the CD30 antigen as a common immunophenotypic hallmark. There is a wide spectrum of management options depending on factors such as extent of disease, staging and treatment tolerability. This Clinical Practice Statement is reflective of the current clinical practice in Australia.


Assuntos
Papulose Linfomatoide , Transtornos Linfoproliferativos , Neoplasias Cutâneas , Humanos , Austrália , Antígeno Ki-1/metabolismo , Papulose Linfomatoide/diagnóstico , Papulose Linfomatoide/terapia , Papulose Linfomatoide/patologia , Transtornos Linfoproliferativos/diagnóstico , Transtornos Linfoproliferativos/terapia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/terapia , Neoplasias Cutâneas/patologia
2.
Australas J Dermatol ; 62(1): e8-e18, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33368169

RESUMO

Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sézary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).


Assuntos
Micose Fungoide/diagnóstico , Micose Fungoide/terapia , Síndrome de Sézary/diagnóstico , Síndrome de Sézary/terapia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/terapia , Biópsia , Testes Hematológicos , Humanos , Micose Fungoide/mortalidade , Estadiamento de Neoplasias , Prognóstico , Síndrome de Sézary/mortalidade , Pele/patologia , Neoplasias Cutâneas/mortalidade , Taxa de Sobrevida
3.
Australas J Dermatol ; 57(4): 312-315, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26061098

RESUMO

Terminal osseous dysplasia with pigmentary defects (TOD) is an extremely rare X-linked dominant disorder, which is characterised by cutaneous digital fibromas, pigmentary skin defects and skeletal abnormalities. A single mutation in the last nucleotide of exon 31 of the filamin A gene (FLNA) has recently been identified as a cause of the disease. We describe a case of an 18-month-old girl with the clinical phenotype of TOD and the disease-specific FLNA mutation confirmed by genetic testing. This report highlights the importance of recognising this distinct phenotype that can present to a wide variety of health-care professionals, and reviews the spectrum of filamin A disorders.

4.
Australas J Dermatol ; 57(1): e20-2, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25557526

RESUMO

Multiple dermatofibromas is a rare entity consisting of more than fifteen lesions. Multiple clustered dermatofibroma is a distinct variant of multiple dermatofibromas and is defined as a well-demarcated plaque composed of individual dermatofibromas. We report a 16-year-old boy with multiple clustered dermatofibroma in a segmental distribution, which has previously not been reported in the literature.


Assuntos
Histiocitoma Fibroso Benigno/patologia , Neoplasias Primárias Múltiplas/patologia , Neoplasias Cutâneas/patologia , Adolescente , Histiocitoma Fibroso Benigno/diagnóstico , Humanos , Masculino , Neoplasias Primárias Múltiplas/diagnóstico , Neoplasias Cutâneas/diagnóstico
5.
Australas J Dermatol ; 53(2): 155-6, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22571570

RESUMO

A 24-year-old man with a long history of severe atopic eczema presented with a marked exacerbation requiring hospital admission. It emerged that his occupation as an animal house technician required him to work closely with laboratory animals, particularly mice and rats. Radioallergosorbent tests to mice allergens were markedly elevated. Avoidance of animal work, in conjunction with medical treatment, resulted in a marked improvement of his eczema.


Assuntos
Alérgenos/efeitos adversos , Animais de Laboratório/imunologia , Dermatite Atópica/imunologia , Exposição Ocupacional/efeitos adversos , Adulto , Animais , Dermatite Alérgica de Contato/imunologia , Humanos , Masculino , Camundongos , Níquel/efeitos adversos , Urticária/imunologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA